RPRX Royalty Pharma plc | GB00BMVP7Y09
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 3.705.991.360 | 3.469.483.440 | 6.82% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 5,59 | 5,23 | 6.97% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 7 | 6 | 16.67% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |